Anhui Provincial Key Laboratory for Conservation and Exploitation of Biological Resources, School of Life Science, Anhui Normal University, Wuhu, China.
Department of Thoracic Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Clin Exp Immunol. 2021 Oct;206(1):12-27. doi: 10.1111/cei.13634. Epub 2021 Jul 6.
Atherosclerosis is an inflammatory disease with break-down of homeostatic immune regulation of vascular tissues. As a critical initiator of host immunity, dendritic cells (DCs) have also been identified in the aorta of healthy individuals and atherosclerotic patients, whose roles in regulating arterial inflammation aroused great interest. Accumulating evidence has now pointed to the fundamental roles for DCs in every developmental stage of atherosclerosis due to their myriad of functions in immunity and tolerance induction, ranging from lipid uptake, efferocytosis and antigen presentation to pro- and anti-inflammatory cytokine or chemokine secretion. In this study we provide a timely summary of the published works in this field, and comprehensively discuss both the direct and indirect roles of DCs in atherogenesis. Understanding the pathogenic roles of DCs during the development of atherosclerosis in vascular tissues would certainly help to open therapeutic avenue to the treatment of cardiovascular diseases.
动脉粥样硬化是一种炎症性疾病,其血管组织的稳态免疫调节发生了崩溃。树突状细胞(DCs)作为宿主免疫的关键启动者,也在健康个体和动脉粥样硬化患者的主动脉中被发现,其在调节动脉炎症中的作用引起了极大的兴趣。现在,越来越多的证据表明,由于 DCs 在免疫和耐受诱导中具有多种功能,包括脂质摄取、吞噬作用和抗原呈递以及促炎和抗炎细胞因子或趋化因子的分泌,因此它们在动脉粥样硬化的每个发育阶段都起着基础性作用。在本研究中,我们及时总结了该领域的已发表研究成果,并全面讨论了 DCs 在动脉粥样形成中的直接和间接作用。了解 DCs 在血管组织中动脉粥样硬化发展过程中的致病作用,肯定有助于开辟治疗心血管疾病的治疗途径。